论文部分内容阅读
手术后复发是影响肝细胞癌手术疗效的主要原因,近年认为对此应采取积极的再手术治疗.本文报告复发性肝癌再手术10例,第1次术后1、3、5年生存率分别为90%、60%、40%,第2次术后1、2、3年生存率分别为90%、70%、50%.作者就如何提高复发性肝癌的再手术率、再手术指征和方法,及如何减少肝细胞癌术后复发等问题进行了探讨.
Recurrence after surgery is the main reason affecting the curative effect of hepatocellular carcinoma. In recent years, it is believed that active reoperation should be taken. This article reports 10 cases of recurrent hepatocellular carcinoma reoperation. The 1st, 3rd, and 5-year survival rates after the first operation were respectively reported. At 90%, 60%, and 40%, the 1st, 2nd and 3rd year survival rates after the second operation were 90%, 70%, and 50%, respectively. The authors on how to improve the reoperation rate of recurrent liver cancer, reoperation indication And methods, and how to reduce the recurrence of hepatocellular carcinoma and other issues were discussed.